Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1998
06/09/1998US5763479 Naphthoquinone derivatives for the treatment of chronic inflammation
06/09/1998US5763476 Sublingual or buccal pharmaceutical composition
06/09/1998US5763473 Use of 2-substituted benzimidazole as smooth muscle cell proliferation inhibitors
06/09/1998US5763471 Melatoninergic agonist spiro indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products
06/09/1998US5763470 Benzopyran compounds and methods for their use
06/09/1998US5763467 Hypoglycemic hydroxyurea derivatives
06/09/1998US5763460 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-htia receptor antagonists
06/09/1998US5763459 5-ht receptor antagonist
06/09/1998US5763458 1-phenylalkanone 5-HT4 receptor ligands
06/09/1998US5763457 Method for treating anxiety
06/09/1998US5763456 Benzoylecgonine, ecgonine and ecgonidine derivatives
06/09/1998US5763455 Biologically active tropane derivatives
06/09/1998US5763454 Antibacterial agent
06/09/1998US5763453 Antitumor agents
06/09/1998US5763452 Nonsteroid antiarthritic antiinflammatory agents
06/09/1998US5763450 Substituted benzyl pyrimidines
06/09/1998US5763449 Aqueous medium containing polyvinylpyrrolidone, c3-c6 polyol, ammonium glycyrrhizinate, flavors
06/09/1998US5763448 Schizophrenia
06/09/1998US5763447 Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
06/09/1998US5763446 Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases
06/09/1998US5763445 Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
06/09/1998US5763444 Central nervous system agents
06/09/1998US5763443 Treatment of patients who have built up multi-drug resistance to substances used in cancer treatment
06/09/1998US5763442 Anti-parasitic activity
06/09/1998US5763441 Administering to the patient suffering from diabetes, glioma, hemangioma, kaposi's sarcoma, ovarian/breast/pancreatic/colon and prostate cancer a benzo(g)quinoxaline compounds
06/09/1998US5763437 Benzodiazepine derivatives
06/09/1998US5763436 Guanidine derivatives
06/09/1998US5763435 Administering to mammal to treat liver disease or inflammatory condition of gastrointestinal tract
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763431 Method for regulating neuropeptide hormone secretion
06/09/1998US5763429 Method of treating prostatic diseases using active vitamin D analogues
06/09/1998US5763428 Administering active nontoxic derivatives for skin or metabolic disorders
06/09/1998US5763426 Dissolving calcipotriol in organic solvent and adding water to the solution to precipitate the hydrate; storage stability; useful for treatment of psoriasis
06/09/1998US5763425 Gastrointestinal toxicity side effect inhibition
06/09/1998US5763422 Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
06/09/1998US5763421 Heparin derivatives having antimetastatic activity
06/09/1998US5763420 Method for modulating the immune system
06/09/1998US5763418 Nucleotide antitumor agents
06/09/1998US5763417 Protection from septic shock subsequent to injury by dsRNAs
06/09/1998US5763414 Administering to mammal to treat hypercholesterolemia
06/09/1998US5763399 Revitalizing tissues with growth factor
06/09/1998US5763398 Sprayable aqueous solution for drug delivery yields uniform plasma levels of the desmopressin peptide
06/09/1998US5763397 Glycopeptides, a process for their preparation and their use
06/09/1998US5763393 Ability to bind n-methylasperate receptors; treatment fornervous system disorders
06/09/1998US5763392 Nutritional supplyment for reducing blood glucose concentration
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5762963 Dispersing in solid or gel vehicle in which concentration of capsaicinoid decreases from center toward periphery; for mouth, throat pain relief
06/09/1998US5762960 Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression using preferential/discriminatory serotonin reuptake inhibitors
06/09/1998US5762956 Multilayer drug delivery system with backings with estrogen and progestin hormones, adhesives and permeation enhancing agents
06/09/1998US5762954 Comprises a pressure sensitive adhesive layer formed on a flexible support, adhesive being composed of polysiloxane and copolymer of vinyl acetate, and isosorbide dinitrate; useful for drug delivery; sustained release
06/09/1998US5762953 Memory function
06/09/1998US5762952 Transdermal delivery of active drugs
06/09/1998US5762943 And deacylated monophosphoryl lipid, carrier, and allergen
06/09/1998US5762940 Methods and compositions for inhibiting or destroying viruses or retroviruses
06/09/1998US5762936 Antioxidant derived from lentil and its preparation and uses
06/09/1998US5762935 Anti-inflammatory and infection protective effects of sesamin-based lignans
06/09/1998US5762922 Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
06/09/1998US5762919 Consists of a polymerizable cyanoacrylate ester, an antimicrobially effective complex of iodine and biocompatible polymer and sulfur dioxide polymerization inhibitor
06/09/1998US5762917 Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring
06/09/1998US5762911 Anti-caries oral compositions
06/09/1998CA2157142C Treatment of diseases caused by sebaceous gland disorders
06/09/1998CA2148078C Platelet aggregation inhibitor
06/09/1998CA2120133C Crystalline amifostine compositions and methods for the preparation and use of same
06/09/1998CA2111223C Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
06/09/1998CA2077907C Use of spiperone as an immunosuppressant and anti-inflammatory agent
06/09/1998CA2040011C Thiazole and imidazole derivatives and antiulcer composition containing same
06/09/1998CA2027483C Process for the preparation of an aqueous effervescent solution with emollient action on nail cuticle, composition for said process and corresponding cosmetic treatment
06/06/1998CA2224535A1 Method of assessing and improving membrane function and composition therefor
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998WO1998023648A1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
06/04/1998WO1998023627A1 Glycolipid mimics and methods of use thereof
06/04/1998WO1998023625A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998WO1998023622A1 Purification of fermented clavulanic acid
06/04/1998WO1998023621A1 Cephalosporin derivatives
06/04/1998WO1998023619A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
06/04/1998WO1998023617A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998WO1998023616A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998WO1998023614A1 Novel phenanethridinium derivatives
06/04/1998WO1998023613A1 Fused bicyclic pyrimidine derivatives
06/04/1998WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023608A1 Novel integrin receptor antagonists
06/04/1998WO1998023607A1 1,4-dihydropyridine derivatives
06/04/1998WO1998023603A1 Dimesylate salts of neuropeptide y ligands
06/04/1998WO1998023597A1 4,5-diaminopyrimidine derivatives and a method for the preparation thereof
06/04/1998WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023594A1 Cytotrienins, process for preparing the same, and antitumor agent
06/04/1998WO1998023593A1 Apo b-secretion/mtp inhibitory amides
06/04/1998WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023588A1 Metalloproteinase inhibitors
06/04/1998WO1998023587A1 5-cyclo indole compounds as 5-ht1d receptor ligands
06/04/1998WO1998023581A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998WO1998023575A1 Asiatic acid derivatives having modified a-ring
06/04/1998WO1998023574A1 Asiatic acid derivatives and medicines for treating wounds, which contains the same
06/04/1998WO1998023565A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
06/04/1998WO1998023294A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998WO1998023292A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
1 ... 6645 6646 6647 6648 6649 6650 6651 6652 6653 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 ... 7860